Showing results (421-430 of 480) with videos related to

Sort By:
Pageof 48
Journal of Virology|March 30, 2012
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza virusesJens C Krause, Tshidi Tsibane, Terrence M Tumpey, et al.
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Cancer Research|August 12, 1998
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrierG E Tomlinson, T T Chen, V A Stastny, et al.
BMC Research Notes|December 6, 2013
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signalingFrankie Ann Holmes, Virginia Espina, Lance A Liotta, et al.
JCO Precision Oncology|August 18, 2025
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS StudyDebu Tripathy, Joanne L Blum, Hong Zhang, et al.
Endoscopy|March 1, 1997
Comparison between esophageal Wallstent and Ultraflex stents in the treatment of malignant stenoses of the esophagus and cardiaG Dorta, J Binek, A L Blum, et al.
Gastroenterology|March 26, 1999
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adultsP Michetti, C Kreiss, K L Kotloff, et al.
Cancer Medicine|March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancerFrankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
The Oncologist|June 15, 2023
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II StudyJennifer K Litton, J Thaddeus Beck, Jason M Jones, et al.
Pageof 48